ACYCLOVIR OINT (CCHP2017)

Similar documents
ACYCLOVIR OINT (CCHP2017)

ACYCLOVIR OINT (CCHP2017)

ACYCLOVIR OINT (CCHP2017)

ACYCLOVIR OINT (CCHP2017)

ALZHEIMER'S DRUGS. Details. Step 2: Exelon Patch 13.3 mg/24 hour transdermal Exelon Patch 4.6 mg/24 hr transdermal

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

2015 Chinese Community Health Plan Senior Program (HMO) Step Therapy Criteria Last Updated 11/1/2015

Plan Year CCHP Senior Program (HMO) Step Therapy Criteria (ST)

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

Step Therapy Requirements. Effective: 05/01/2018

ANTICONVULSANTS. Details

Step Therapy Requirements. Effective: 11/01/2018

Step Therapy Requirements

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release

2017 Step Therapy Criteria

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E

ALLERGIC CONJUNCTIVITIS AGENTS

ALPHA BLOCKERS. Products Affected. Details. Step 2: RAPAFLO 4 MG CAPSULE. Step 1: alfuzosin extended release tablet doxazosin tablet

Step Therapy Requirements. Effective: 1/1/2019

2018 PDP Premier Step Therapy Document September 2018 Y0114_18_33144_I_009

FirstCarolinaCare Insurance Company. Step Therapy Requirements

ANTIDIABETIC AGENTS - MISCELLANEOUS

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release

ANTIDIABETIC AGENTS - MISCELLANEOUS

2019 PDP Basic Step Therapy Document

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

2018 Step Therapy FID 18088

ANTICONVULSANTS. Details

2019 Simply Step Therapy Document

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release

2015 Step Therapy Prior Authorization Medical Necessity Guidelines

Drugs That Require Step Therapy (ST) Step Therapy Medications

ANTIDIABETIC AGENTS - MISCELLANEOUS

JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

Simply Step Therapy Document September 2018 Y0114_18_33074_I_009

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO) and Stride SM Value Rx Plus (HMO) Step Therapy Requirements

Step Therapy Medications

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO), Stride SM Value Rx Plus (HMO) and Stride SM Gain Rx (HMO)

Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017

ANTICONVULSANT STEP THERAPY

2018 STEP THERAPY CRITERIA UCare Connect (SNBC) MinnesotaCare Prepaid Medical Assistance Program (PMAP) Minnesota Senior Care Plus (MSC+)

ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 04/01/2019

ANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

2018 Step Therapy Criteria

ADHD STIMULANTS-S(SHC)

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES

ANTIDEPRESSANTS. Details. Step Therapy 2017 Last Updated: 5/23/2017

Step Therapy Requirements

Alprazolam 0.25mg, 0.5mg, 1mg tablets

**CRITERIA UNDER CMS REVIEW**

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

Antidepressant Prior Authorization Request

2018 GRS Premier Step Therapy Document. September 2018 Y0114_18_33177_I_010

ALPHA GLUCOSIDASE INHIBITOR THERAPY

Step Therapy Requirements. Effective: 12/01/2016

WELLCARE/ OHANA HEALTH PLAN 2015 STEP THERAPY CRITERIA (No Changes Made Since: 08/2015)

Step Therapy Requirements. Effective: 03/01/2015

Attention: Behavioral Health Providers, Pharmacists and Prescribers N.C. Medicaid and N.C. Health Choice Preferred Drug List Changes - UPDATE

FirstCarolinaCare Insurance Company Step Therapy Requirements

ANTICONVULSANTS. Details. Step Therapy Criteria Date Effective: April 1, 2019

COLCRYS-PST. Products Affected Step 1: Mitigare 0.6 mg capsule. Details. Step 2: Colcrys 0.6 mg tablet

Step Therapy Requirements

2019 GRS Premier Step Therapy Document

COLCRYS-PST. Products Affected Step 1: Mitigare 0.6 mg capsule. Details. Step 2: Colcrys 0.6 mg tablet

Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*

PHYSICIAN REFERENCE ANTIDEPRESSANT DOSING GUIDELINES

Acyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria

SmithRx Standard Formulary Step Therapy List

Y0133_StepTherapyCriteria _C 10/18/18 Y0133_StepTherapyCriteria _C es 10/18/18

Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir

Antidepressant Agents Step Therapy and Quantity Limit Program Summary

2018 WPS MedicareRx Plan (PDP) Step Therapy

Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist

BRINTELLIX. Step Therapy Criteria HealthTeam Advantage Formulary ID: Version 6 Effective Date: 1/1/2016. PRODUCT(s) AFFECTED BRINTELLIX

Aetna Better Health of Illinois Medicaid Formulary Updates

ANTIEMETICS STEP. Step Therapy Requirements Effective April 1, 2019

ALOGLIPTIN STEP. Step Therapy Requirements Effective April 1, 2018

Table 1: Price increases for Brand Name Drugs with Generic Equivalents

BRIEF ANTIDEPRESSANT OVERVIEW. Casey Gallimore, Pharm.D., M.S.

ALOGLIPTIN STEP. Step Therapy Requirements Effective June 1, 2018

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children

Transcription:

ACYCLOVIR OINT (CCHP2017) acyclovir 5 % topical ointment Step Therapy requires trial of one (1) of the following: oral generic acyclovir, oral generic famciclovir, oral generic valacyclovir. 1

ALPHAGAN (CCHP2017) ALPHAGAN P 0.1 % EYE DROPS Step Therapy requires trial of brimonidine 0.15%. 2

ANTIDEPRESSANT_NVT 2017 DESVENLAFAXINE ER 100 MG TABLET,EXTENDED RELEASE 24 HR DESVENLAFAXINE ER 50 MG TABLET,EXTENDED RELEASE 24 HR DESVENLAFAXINE FUMARATE ER 100 MG TABLET, EXTENDED RELEASE 24 HR DESVENLAFAXINE FUMARATE ER 50 MG TABLET, EXTENDED RELEASE 24 HR duloxetine 40 mg capsule,delayed release EMSAM 12 MG/24 HR TRANSDERMAL 24 HOUR PATCH EMSAM 6 MG/24 HR TRANSDERMAL 24 HOUR PATCH EMSAM 9 MG/24 HR TRANSDERMAL 24 HOUR PATCH FETZIMA 120 MG CAPSULE,EXTENDED RELEASE FETZIMA 20 MG (2)-40 MG (26) CAPSULE,EXTENDED RELEASE,24 HR,DOSE PACK FETZIMA 20 MG CAPSULE,EXTENDED RELEASE FETZIMA 40 MG CAPSULE,EXTENDED RELEASE FETZIMA 80 MG CAPSULE,EXTENDED RELEASE fluvoxamine er 100 mg capsule,extended release 24 hr fluvoxamine er 150 mg capsule,extended release 24 hr MARPLAN 10 MG TABLET TRINTELLIX 10 MG TABLET TRINTELLIX 20 MG TABLET TRINTELLIX 5 MG TABLET VIIBRYD 10 MG (7)-20 MG (23) TABLETS IN A DOSE PACK VIIBRYD 10 MG TABLET VIIBRYD 20 MG TABLET VIIBRYD 40 MG TABLET Step Therapy requires trial of one of the following generic SSRI's in previous 120 days: escitalopram, sertraline, fluoxetine, citalopram, paroxetine, Paxil oral solution, or fluvoxamine. If request is for duloxetine, step not required for diabetic peripheral neuropathy, fibromyalgia, or chronic musculoskeletal pain. 3

ARICEPT 23_NVT 2015 donepezil 10 mg disintegrating tablet donepezil 5 mg disintegrating tablet Step Therapy requires trial of regular donepezil 5 mg or 10mg oral tablets in previous 120 days. 4

DEXILANT_2019 DEXILANT 30 MG CAPSULE, DELAYED RELEASE DEXILANT 60 MG CAPSULE, DELAYED RELEASE Step therapy requires trial of lansoprazole in the previous 120 days. 5

DRY EYE OTC (CCHP 2018) RESTASIS 0.05 % EYE DROPS IN A DROPPERETTE Step Therapy requires trial of OTC artificial tears. 6

OPHTHALMIC ANTI-INFECTIVES_NVT 2015 BESIVANCE 0.6 % EYE DROPS,SUSPENSION gatifloxacin 0.5 % eye drops Step Therapy requires trial of one of the following ciprofloxacin, levofloxacin, or ofloxacinin previous 120 days. 7

PANCREATIC ENZYMES_NVT 2015 PANCREAZE 10,500 UNIT-35,500 UNIT-61,500 UNIT CAPSULE,DELAYED RELEASE PANCREAZE 16,800 UNIT-56,800 UNIT-98,400 UNIT CAPSULE,DELAYED RELEASE PANCREAZE 2,600 UNIT-6,200 UNIT- 10,850 UNIT CAPSULE,DELAYED RELEASE PANCREAZE 21,000 UNIT-54,700 UNIT-83,900 UNIT CAPSULE,DELAYED RELEASE PANCREAZE 4,200 UNIT-14,200 UNIT- 24,600 UNIT CAPSULE,DELAYED RELEASE Step Therapy requires trial of CREON in previous 120 days. 8

PENTASA_NVT 2015 APRISO 0.375 GRAM CAPSULE,EXTENDED RELEASE DELZICOL 400 MG CAPSULE (DR TABLETS INSIDE) LIALDA 1.2 GRAM TABLET,DELAYED RELEASE Step Therapy requires trial of one of the following: mesalamine delayedrelease 1.2gm, or mesalamine DR 800 mg in previous 120 days. 9

ST_RIVASTIGMINE_2019 rivastigmine 13.3 mg/24 hour transdermal patch rivastigmine 4.6 mg/24 hour transdermal patch rivastigmine 9.5 mg/24 hour transdermal patch Step Therapy requires trial of rivastigmine tablets in past 120 days. 10

ST_SMOKINGCESS_2019 ZYBAN 150 MG TABLET,EXTENDED RELEASE Step therapy requires trial of Nicoderm patches in previous 120 days. 11

ULORIC_NVT 2015 ULORIC 40 MG TABLET ULORIC 80 MG TABLET Step Therapy requires trial of allopurinol in previous 120 days. 12

ZADITOR OTC (CCHP2017) olopatadine 0.1 % eye drops Step 3: olopatadine 0.2 % eye drops PAZEO 0.7 % EYE DROPS Step Therapy requires trial of OTC zaditor/ketotifen for olopatadine ophth soln. Trial of olopatadine 1 mg/ml ophth soln required for olopatadine 2 mg/ml and PAZEO 13

INDEX A acyclovir 5 % topical ointment... 1 ALPHAGAN P 0.1 % EYE DROPS... 2 APRISO 0.375 GRAM CAPSULE,EXTENDED RELEASE... 9 B BESIVANCE 0.6 % EYE DROPS,SUSPENSION... 7 D DELZICOL 400 MG CAPSULE (DR TABLETS INSIDE)... 9 DESVENLAFAXINE ER 100 MG TABLET,EXTENDED RELEASE 24 HR... 3 DESVENLAFAXINE ER 50 MG TABLET,EXTENDED RELEASE 24 HR... 3 DESVENLAFAXINE FUMARATE ER 100 MG TABLET, EXTENDED RELEASE 24 HR... 3 DESVENLAFAXINE FUMARATE ER 50 MG TABLET, EXTENDED RELEASE 24 HR... 3 DEXILANT 30 MG CAPSULE, DELAYED RELEASE... 5 DEXILANT 60 MG CAPSULE, DELAYED RELEASE... 5 donepezil 10 mg disintegrating tablet... 4 donepezil 5 mg disintegrating tablet... 4 duloxetine 40 mg capsule,delayed release.. 3 E EMSAM 12 MG/24 HR TRANSDERMAL 24 HOUR PATCH... 3 EMSAM 6 MG/24 HR TRANSDERMAL 24 HOUR PATCH... 3 EMSAM 9 MG/24 HR TRANSDERMAL 24 HOUR PATCH... 3 F FETZIMA 120 MG CAPSULE,EXTENDED RELEASE... 3 FETZIMA 20 MG (2)-40 MG (26) CAPSULE,EXTENDED RELEASE,24 HR,DOSE PACK... 3 FETZIMA 20 MG CAPSULE,EXTENDED RELEASE... 3 FETZIMA 40 MG CAPSULE,EXTENDED RELEASE... 3 FETZIMA 80 MG CAPSULE,EXTENDED RELEASE... 3 fluvoxamine er 100 mg capsule,extended release 24 hr... 3 fluvoxamine er 150 mg capsule,extended release 24 hr... 3 G gatifloxacin 0.5 % eye drops... 7 L LIALDA 1.2 GRAM TABLET,DELAYED RELEASE... 9 M MARPLAN 10 MG TABLET... 3 O olopatadine 0.1 % eye drops... 13 olopatadine 0.2 % eye drops... 13 P PANCREAZE 10,500 UNIT-35,500 UNIT- 61,500 UNIT CAPSULE,DELAYED RELEASE... 8 PANCREAZE 16,800 UNIT-56,800 UNIT- 98,400 UNIT CAPSULE,DELAYED RELEASE... 8 PANCREAZE 2,600 UNIT-6,200 UNIT- 10,850 UNIT CAPSULE,DELAYED RELEASE... 8 PANCREAZE 21,000 UNIT-54,700 UNIT- 83,900 UNIT CAPSULE,DELAYED RELEASE... 8 PANCREAZE 4,200 UNIT-14,200 UNIT- 24,600 UNIT CAPSULE,DELAYED RELEASE... 8 PAZEO 0.7 % EYE DROPS... 13 14

R RESTASIS 0.05 % EYE DROPS IN A DROPPERETTE... 6 rivastigmine 13.3 mg/24 hour transdermal patch... 10 rivastigmine 4.6 mg/24 hour transdermal patch... 10 rivastigmine 9.5 mg/24 hour transdermal patch... 10 T TRINTELLIX 10 MG TABLET... 3 TRINTELLIX 20 MG TABLET... 3 TRINTELLIX 5 MG TABLET... 3 U ULORIC 40 MG TABLET... 12 ULORIC 80 MG TABLET... 12 V VIIBRYD 10 MG (7)-20 MG (23) TABLETS IN A DOSE PACK... 3 VIIBRYD 10 MG TABLET... 3 VIIBRYD 20 MG TABLET... 3 VIIBRYD 40 MG TABLET... 3 Z ZYBAN 150 MG TABLET,EXTENDED RELEASE... 11 15